Búsqueda | Biblioteca Virtual en Salud Fronteriza

1.

Blood-Based Biomarkers for Predicting Immunotherapy Benefit in Lung Cancer.

Camidge, D Ross; Schenk, Erin L.

Cell ; 183(2): 303-304, 2020 10 15.

Artículo en Inglés | MEDLINE | ID: mdl-33064985

2.

Repotrectinib in ROS1 Fusion-Positive Non-Small-Cell Lung Cancer.

Drilon, Alexander; Camidge, D Ross; Lin, Jessica J; Kim, Sang-We; Solomon, Benjamin J; Dziadziuszko, Rafal; Besse, Benjamin; Goto, Koichi; de Langen, Adrianus Johannes; Wolf, Jürgen; Lee, Ki Hyeong; Popat, Sanjay; Springfeld, Christoph; Nagasaka, Misako; Felip, Enriqueta; Yang, Nong; Velcheti, Vamsidhar; Lu, Shun; Kao, Steven; Dooms, Christophe; Krebs, Matthew G; Yao, Wenxiu; Beg, Muhammad Shaalan; Hu, Xiufeng; Moro-Sibilot, Denis; Cheema, Parneet; Stopatschinskaja, Shanna; Mehta, Minal; Trone, Denise; Graber, Armin; Sims, Gregory; Yuan, Yong; Cho, Byoung Chul.

N Engl J Med ; 390(2): 118-131, 2024 Jan 11.

Artículo en Inglés | MEDLINE | ID: mdl-38197815

3.

Real-World Efficacy and Tolerability of Brigatinib in Patients with Non-Small Cell Lung Cancer with Prior ALK-TKIs in the United States.

Jahanzeb, Mohammad; Lin, Huamao M; Wu, Yanyu; Zhang, Pingkuan; Gorritz, Magdaliz; McGuiness, Catherine B; Huang, Wei-Ti; Sun, Kainan; Chen, Chi-Chang; Camidge, D Ross.

Oncologist ; 27(9): 790-798, 2022 09 02.

Artículo en Inglés | MEDLINE | ID: mdl-35781589

4.

Effectiveness of crizotinib versus entrectinib in ROS1-positive non-small-cell lung cancer using clinical and real-world data.

Tremblay, Gabriel; Groff, Michael; Iadeluca, Laura; Daniele, Patrick; Wilner, Keith; Wiltshire, Robin; Bartolome, Lauren; Usari, Tiziana; Cappelleri, Joseph C; Camidge, D Ross.

Future Oncol ; 18(17): 2063-2074, 2022 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-35232230

5.

Indirect comparisons of brigatinib and alectinib for front-line ALK-positive non-small-cell lung cancer.

Reckamp, Karen L; Lin, Huamao M; Cranmer, Holly; Wu, Yanyu; Zhang, Pingkuan; Walton, Laura J; Kay, Stephen; Cichewicz, Allie; Neupane, Binod; Fahrbach, Kyle; Popat, Sanjay; Camidge, D Ross.

Future Oncol ; 18(20): 2499-2510, 2022 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-35608148

6.

First-In-Human, First-In-Class, Phase I Trial of the Fucosylation Inhibitor SGN-2FF in Patients with Advanced Solid Tumors.

Do, Khanh T; Chow, Laura Quan Man; Reckamp, Karen; Sanborn, Rachel E; Burris, Howard; Robert, Francisco; Camidge, D Ross; Steuer, Conor E; Strickler, John H; Weise, Amy; Specht, Jennifer M; Gutierrez, Martin; Haughney, Peter; Hengel, Shawna; Derleth, Christina Louise; Yap, Timothy A.

Oncologist ; 26(11): 925-e1918, 2021 11.

Artículo en Inglés | MEDLINE | ID: mdl-34288257

7.

Brigatinib versus Crizotinib in ALK-Positive Non-Small-Cell Lung Cancer.

Camidge, D Ross; Kim, Hye Ryun; Ahn, Myung-Ju; Yang, James Chih-Hsin; Han, Ji-Youn; Lee, Jong-Seok; Hochmair, Maximilian J; Li, Jacky Yu-Chung; Chang, Gee-Chen; Lee, Ki Hyeong; Gridelli, Cesare; Delmonte, Angelo; Garcia Campelo, Rosario; Kim, Dong-Wan; Bearz, Alessandra; Griesinger, Frank; Morabito, Alessandro; Felip, Enriqueta; Califano, Raffaele; Ghosh, Sharmistha; Spira, Alexander; Gettinger, Scott N; Tiseo, Marcello; Gupta, Neeraj; Haney, Jeff; Kerstein, David; Popat, Sanjay.

N Engl J Med ; 379(21): 2027-2039, 2018 11 22.

Artículo en Inglés | MEDLINE | ID: mdl-30280657

8.

Race and ethnicity representation in clinical trials: findings from a literature review of Phase I oncology trials.

Camidge, D Ross; Park, Haeseong; Smoyer, Karen E; Jacobs, Ira; Lee, Lauren J; Askerova, Zemfira; McGinnis, Justin; Zakharia, Yousef.

Future Oncol ; 17(24): 3271-3280, 2021 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-34047192

9.

Alectinib versus Crizotinib in Untreated ALK-Positive Non-Small-Cell Lung Cancer.

Peters, Solange; Camidge, D Ross; Shaw, Alice T; Gadgeel, Shirish; Ahn, Jin S; Kim, Dong-Wan; Ou, Sai-Hong I; Pérol, Maurice; Dziadziuszko, Rafal; Rosell, Rafael; Zeaiter, Ali; Mitry, Emmanuel; Golding, Sophie; Balas, Bogdana; Noe, Johannes; Morcos, Peter N; Mok, Tony.

N Engl J Med ; 377(9): 829-838, 2017 08 31.

Artículo en Inglés | MEDLINE | ID: mdl-28586279

10.

Incidence of pneumonitis/interstitial lung disease induced by HER2-targeting therapy for HER2-positive metastatic breast cancer.

Hackshaw, Michelle D; Danysh, Heather E; Singh, Jasmeet; Ritchey, Mary E; Ladner, Amy; Taitt, Corina; Camidge, D Ross; Iwata, Hiroji; Powell, Charles A.

Breast Cancer Res Treat ; 183(1): 23-39, 2020 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-32591987

11.

Dose-escalation trial of the ALK, MET & ROS1 inhibitor, crizotinib, in patients with advanced cancer.

Clark, Jeffrey W; Camidge, D Ross; Kwak, Eunice L; Maki, Robert G; Shapiro, Geoffrey I; Chen, Isan; Tan, Weiwei; Randolph, Sophia; Christensen, James G; Ozeck, Mark; Tang, Yiyun; Wilner, Keith D; Salgia, Ravi.

Future Oncol ; 16(1): 4289-4301, 2020 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-31778074

12.

Predictive value of oncogenic driver subtype, programmed death-1 ligand (PD-L1) score, and smoking status on the efficacy of PD-1/PD-L1 inhibitors in patients with oncogene-driven non-small cell lung cancer.

Ng, Terry L; Liu, Yiwei; Dimou, Anastasios; Patil, Tejas; Aisner, Dara L; Dong, Zhengwei; Jiang, Tao; Su, Chunxia; Wu, Chunyan; Ren, Shengxiang; Zhou, Caicun; Camidge, D Ross.

Cancer ; 125(7): 1038-1049, 2019 04 01.

Artículo en Inglés | MEDLINE | ID: mdl-30548240

13.

Lorlatinib in patients with ALK-positive non-small-cell lung cancer: results from a global phase 2 study.

Solomon, Benjamin J; Besse, Benjamin; Bauer, Todd M; Felip, Enriqueta; Soo, Ross A; Camidge, D Ross; Chiari, Rita; Bearz, Alessandra; Lin, Chia-Chi; Gadgeel, Shirish M; Riely, Gregory J; Tan, Eng Huat; Seto, Takashi; James, Leonard P; Clancy, Jill S; Abbattista, Antonello; Martini, Jean-François; Chen, Joseph; Peltz, Gerson; Thurm, Holger; Ou, Sai-Hong Ignatius; Shaw, Alice T.

Lancet Oncol ; 19(12): 1654-1667, 2018 12.

Artículo en Inglés | MEDLINE | ID: mdl-30413378

14.

Clinical trial design for systemic agents in patients with brain metastases from solid tumours: a guideline by the Response Assessment in Neuro-Oncology Brain Metastases working group.

Camidge, D Ross; Lee, Eudocia Q; Lin, Nancy U; Margolin, Kim; Ahluwalia, Manmeet S; Bendszus, Martin; Chang, Susan M; Dancey, Janet; de Vries, Elisabeth G E; Harris, Gordon J; Hodi, F Stephen; Lassman, Andrew B; Macdonald, David R; Peereboom, David M; Schiff, David; Soffietti, Ricardo; van den Bent, Martin J; Wefel, Jeffrey S; Wen, Patrick Y.

Lancet Oncol ; 19(1): e20-e32, 2018 01.

Artículo en Inglés | MEDLINE | ID: mdl-29304358

15.

Rociletinib in EGFR-mutated non-small-cell lung cancer.

Sequist, Lecia V; Soria, Jean-Charles; Goldman, Jonathan W; Wakelee, Heather A; Gadgeel, Shirish M; Varga, Andrea; Papadimitrakopoulou, Vassiliki; Solomon, Benjamin J; Oxnard, Geoffrey R; Dziadziuszko, Rafal; Aisner, Dara L; Doebele, Robert C; Galasso, Cathy; Garon, Edward B; Heist, Rebecca S; Logan, Jennifer; Neal, Joel W; Mendenhall, Melody A; Nichols, Suzanne; Piotrowska, Zofia; Wozniak, Antoinette J; Raponi, Mitch; Karlovich, Chris A; Jaw-Tsai, Sarah; Isaacson, Jeffrey; Despain, Darrin; Matheny, Shannon L; Rolfe, Lindsey; Allen, Andrew R; Camidge, D Ross.

N Engl J Med ; 372(18): 1700-9, 2015 Apr 30.

Artículo en Inglés | MEDLINE | ID: mdl-25923550

16.

Ceritinib in ALK-rearranged non-small-cell lung cancer.

Shaw, Alice T; Kim, Dong-Wan; Mehra, Ranee; Tan, Daniel S W; Felip, Enriqueta; Chow, Laura Q M; Camidge, D Ross; Vansteenkiste, Johan; Sharma, Sunil; De Pas, Tommaso; Riely, Gregory J; Solomon, Benjamin J; Wolf, Juergen; Thomas, Michael; Schuler, Martin; Liu, Geoffrey; Santoro, Armando; Lau, Yvonne Y; Goldwasser, Meredith; Boral, Anthony L; Engelman, Jeffrey A.

N Engl J Med ; 370(13): 1189-97, 2014 Mar 27.

Artículo en Inglés | MEDLINE | ID: mdl-24670165

17.

Crizotinib in ROS1-rearranged non-small-cell lung cancer.

Shaw, Alice T; Ou, Sai-Hong I; Bang, Yung-Jue; Camidge, D Ross; Solomon, Benjamin J; Salgia, Ravi; Riely, Gregory J; Varella-Garcia, Marileila; Shapiro, Geoffrey I; Costa, Daniel B; Doebele, Robert C; Le, Long Phi; Zheng, Zongli; Tan, Weiwei; Stephenson, Patricia; Shreeve, S Martin; Tye, Lesley M; Christensen, James G; Wilner, Keith D; Clark, Jeffrey W; Iafrate, A John.

N Engl J Med ; 371(21): 1963-71, 2014 Nov 20.

Artículo en Inglés | MEDLINE | ID: mdl-25264305

18.

Activity and safety of ceritinib in patients with ALK-rearranged non-small-cell lung cancer (ASCEND-1): updated results from the multicentre, open-label, phase 1 trial.

Kim, Dong-Wan; Mehra, Ranee; Tan, Daniel S W; Felip, Enriqueta; Chow, Laura Q M; Camidge, D Ross; Vansteenkiste, Johan; Sharma, Sunil; De Pas, Tommaso; Riely, Gregory J; Solomon, Benjamin J; Wolf, Jürgen; Thomas, Michael; Schuler, Martin; Liu, Geoffrey; Santoro, Armando; Sutradhar, Santosh; Li, Siyu; Szczudlo, Tomasz; Yovine, Alejandro; Shaw, Alice T.

Lancet Oncol ; 17(4): 452-463, 2016 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-26973324

19.

Alectinib in ALK-positive, crizotinib-resistant, non-small-cell lung cancer: a single-group, multicentre, phase 2 trial.

Shaw, Alice T; Gandhi, Leena; Gadgeel, Shirish; Riely, Gregory J; Cetnar, Jeremy; West, Howard; Camidge, D Ross; Socinski, Mark A; Chiappori, Alberto; Mekhail, Tarek; Chao, Bo H; Borghaei, Hossein; Gold, Kathryn A; Zeaiter, Ali; Bordogna, Walter; Balas, Bogdana; Puig, Oscar; Henschel, Volkmar; Ou, Sai-Hong Ignatius.

Lancet Oncol ; 17(2): 234-242, 2016 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-26708155

20.

Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study.

Gomez, Daniel R; Blumenschein, George R; Lee, J Jack; Hernandez, Mike; Ye, Rong; Camidge, D Ross; Doebele, Robert C; Skoulidis, Ferdinandos; Gaspar, Laurie E; Gibbons, Don L; Karam, Jose A; Kavanagh, Brian D; Tang, Chad; Komaki, Ritsuko; Louie, Alexander V; Palma, David A; Tsao, Anne S; Sepesi, Boris; William, William N; Zhang, Jianjun; Shi, Qiuling; Wang, Xin Shelley; Swisher, Stephen G; Heymach, John V.

Lancet Oncol ; 17(12): 1672-1682, 2016 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-27789196

Biblioteca Virtual en Salud Fronteriza

México - Estados Unidos

Su selección (0)

Formato de exportación:

Exportar: